| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.092 | 0.04 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |